NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma

被引：0
|
作者：
Andrew Menzies-Gow
Gene Colice
Janet M. Griffiths
Gun Almqvist
Sandhia Ponnarambil
Primal Kaur
Gennaro Ruberto
Karin Bowen
Åsa Hellqvist
May Mo
Esther Garcia Gil
机构：
[1] Royal Brompton Hospital,Late Respiratory & Immunology
[2] BioPharmaceuticals R&D,Translational Science and Experimental Medicine, Early Respiratory & Immunology
[3] AstraZeneca,Late Respiratory & Immunology
[4] BioPharmaceuticals R&D,Late Respiratory & Immunology
[5] AstraZeneca,BioPharma Study Management, Late Respiratory & Immunology
[6] BioPharmaceuticals R&D,Biometrics, Late Respiratory & Immunology
[7] AstraZeneca,Biometrics, Late Respiratory & Immunology
[8] BioPharmaceuticals R&D,Global Medical Respiratory
[9] AstraZeneca,undefined
[10] Amgen,undefined
[11] BioPharmaceuticals R&D,undefined
[12] AstraZeneca,undefined
[13] BioPharmaceuticals R&D,undefined
[14] AstraZeneca,undefined
[15] BioPharmaceuticals R&D,undefined
[16] AstraZeneca,undefined
[17] BioPharmaceuticals Medical,undefined
[18] AstraZeneca,undefined
来源：
Respiratory Research | / 21卷
关键词：
Clinical trial; Severe asthma; Tezepelumab; Thymic stromal lymphopoietin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Design of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of tezepelumab in adult patients with severe chronic rhinosinusitis with nasal polyposis (WAYPOINT)
    Han, J. K.
    Li, T.
    Jagadeesh, S.
    Almqvist, G.
    McLaren, J.
    Colice, G.
    Megally, A.
    Pfaar, O.
    Ponnarambil, S.
    Lipworth, B. J.
    ALLERGOLOGIE, 2024, 47 (09)
  • [32] Efficacy and safety of Dimdazenil in the adult insomnia patients: a phase II randomized, multicenter, double-blind, placebo-controlled, and parallel-group study
    Li, Yanpeng
    Zhang, Ruoxi
    Zhou, Yanling
    Bao, Cungang
    Lin, Zhaocun
    Chen, Chunyan
    He, Jingjing
    Jin, Zhiping
    Song, Lihua
    Zhang, Min
    Guo, Sigen
    Jiang, Yu
    Zhao, Zhongxin
    SLEEP, 2024, 47 (02)
  • [33] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED PHASE 2 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF CHIGLITAZAR IN NASH PATIENTS
    You, Hong
    Sun, Yameng
    Wu, Cuisong
    Xin, Guijie
    Zhong, Bihui
    Wu, Xiaofeng
    Liu, Yali
    Shi, Junping
    Zhang, Qin
    Zhao, Yingren
    Gao, Yufeng
    Xin, Yongning
    Zhu, Yueyong
    Wu, Lixian
    Mao, Xiaorong
    Du, Jian
    Shang, Jia
    Sun, Weiwei
    Xu, Jie
    Yu, Zujiang
    Nan, Yuemin
    Sheng, Huiping
    Li, Yue
    Rao, Huiying
    Yu, Chaohui
    Wu, Xiaoning
    Tong, Xiaofei
    HEPATOLOGY, 2024, 80 : S1969 - S1970
  • [34] A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicentre Study to Assess the Efficacy and Safety of the β3 Adrenoceptor Agonist, Mirabegron, in Patients With Symptoms of Overactive Bladder
    Herschorn, Sender
    Barkin, Jack
    Castro-Diaz, David
    Frankel, Jeffrey M.
    Espuna-Pons, Montserrat
    Gousse, Angelo E.
    Stoelzel, Matthias
    Martin, Nancy
    Gunther, Adrie
    Van Kerrebroeck, Philip
    UROLOGY, 2013, 82 (02) : 313 - 320
  • [35] Efficacy and safety of canagliflozin in children and adolescents with type 2 diabetes: a multicentre, randomised, double-blind, parallel-group, phase 3 trial
    Ali, S. R.
    Nadgir, U.
    Gogate, J.
    Shaw, W.
    Fonseca, S.
    Antunes, J.
    DIABETOLOGIA, 2024, 67 : S29 - S29
  • [36] Efficacy and Safety of Lebrikizumab in Severe Uncontrolled Asthma: Results from the Lute and Verse Phase II Randomized, Double-Blind, Placebo-Controlled Trials
    Hanania, Nicola A.
    Noonan, Michael J.
    Corren, Jonathan
    Korenblat, Phillip
    Zheng, Yanan
    Putnam, Wendy
    Murray, Elaine
    Abelardo, Connie
    Scheerens, Heleen
    Maciuca, Romeo
    Gray, Sarah
    Doyle, Ramona
    McClintock, Dana
    Matthews, John G.
    Yen, Karl
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB402 - AB402
  • [37] SAFETY AND TOLERABILITY OF ADJUNCTIVE BRIVARACETAM IN ADULTS WITH UNCONTROLLED EPILEPSY: RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Kwan, P.
    Johnson, M. E.
    Merschhemke, M.
    Lu, S.
    EPILEPSIA, 2010, 51 : 152 - 152
  • [38] A 9-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD
    Arnold, Valerie K.
    Feifel, David
    Earl, Craig Q.
    Yang, Ronghua
    Adler, Lenard A.
    JOURNAL OF ATTENTION DISORDERS, 2014, 18 (02) : 133 - 144
  • [39] Efficacy and safety of rotigotine in Japanese patients with restless legs syndrome: a phase 3, multicenter, randomized, placebo-controlled, double-blind, parallel-group study
    Inoue, Yuichi
    Shimizu, Tetsuo
    Hirata, Koichi
    Uchimura, Naohisa
    Ishigooka, Jun
    Oka, Yasunori
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    SLEEP MEDICINE, 2013, 14 (11) : 1085 - 1091
  • [40] The efficacy of Femal in women with premenstrual syndrome: a randomised, double-blind, parallel-group, placebo-controlled, multicentre study
    Gerhardsen, Gerhard
    Hansen, Anne V.
    Killi, Marianne
    Fornitz, Gitte Gleerup
    Pedersen, Frank
    Roos, Signe Barfod
    ADVANCES IN THERAPY, 2008, 25 (06) : 595 - 607
12345